07:00 AM EDT, 04/25/2024 (MT Newswires) -- Merck ( MRK ) reported Q1 non-GAAP earnings Thursday of $2.07 per share, up from $1.40 a year ago. Analysts polled by Capital IQ expected $1.92. Sales for the quarter ended March 31 were $15.78 billion, up from $14.49 billion a year earlier. Analysts surveyed by Capital IQ expected $15.20 billion. For 2024,...

07:00 AM EDT, 04/25/2024 (MT Newswires) -- Alphabet (GOOGL, GOOG) is due with its Q1 results in the after-hours today. Analysts polled by Capital IQ expect the company to post a profit of $1.50 per share on revenue of $78.7 billion. GOOGL has recorded an earnings-driven after-hours decline in 32 of the last 78 quarters we've tracked, and in 14...

07:01 AM EDT, 04/25/2024 (MT Newswires) -- Sanofi ( SNY ) reported Q1 non-IFRS business earnings Thursday of 1.78 euros ($1.90) per share, down from 2.16 euros a year earlier. An analyst polled by Capital IQ expected 1.71 euros. Net sales for the quarter were 10.46 million euros, up from 10.22 million euros a year earlier. Analysts polled by Capital...

April 25 (Reuters) - Merck & Co ( MRK ) on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda and human papillomavirus (HPV) vaccine Gardasil. The New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its previous prediction of $8.44 to $8.59,...